Call Number (LC) | Title | Results |
---|---|---|
RM301.25 .P65 2012eb |
Polypharmacology in drug discovery / Polypharmacology in drug discovery |
2 |
RM301.25 .P678 2015eb |
Post-genomic approaches in drug and vaccine development / Post-genomic approaches in drug and vaccine development |
2 |
RM301.25 .P73 2022 | Practical application of supercritical fluid chromatography for pharmaceutical research and development / | 1 |
RM301.25 .P745 2010eb | Preclinical drug development | 1 |
RM301.25 .P75 2002eb | Principles and practice of pharmaceutical medicine / | 1 |
RM301.25 .P75 2010 | ||
RM301.25 .P757 2012eb |
Protein and peptide mass spectrometry in drug discovery / Protein and peptide mass spectrometry in drug discovery |
2 |
RM301.25 .P76 2002 | Proteinase and peptidase inhibition : recent potential targets for drug development / | 1 |
RM301.25 .P76 2002eb | Proteinase and peptidase inhibition : recent potential targets for drug development / | 1 |
RM301.25 .P76 2023 | ||
RM301.25 .Q35 2007eb | Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection. | 1 |
RM301.25 .Q36 2020 | Quantitative methods in pharmaceutical research and development : concepts and applications / | 1 |
RM301.25.R44 2014eb | Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests : Workshop Summary. | 1 |
RM301.25 .R63 2011 | RNA interference application to drug discovery and challenges to pharmaceutical development / | 1 |
RM301.25 .R67 2010 |
The agile approach to adaptive research optimizing efficiency in clinical development / The agile approach to adaptive research : optimizing efficiency in clinical development / |
2 |
RM301.25 .R93 2008 | Real world drug discovery a chemist's guide to biotech and pharmaceutical research / | 1 |
RM301.25 .S384 2013 |
Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases : Second WHO Report on Neglected Tropical Diseases. Practical Pharmacology for the Pharmaceutical Sciences. |
2 |
RM301.25 .S435 1996eb | ||
RM301.25 .S46 2007eb | Statistical issues in drug development / | 1 |
RM301.25 .S46 2021 | Statistical issues in drug development / | 1 |